Long-term Survivorship of Discharged Patients With Malignant Tumor Based on Single-institutional Cancer Registry

Launched by FUDAN UNIVERSITY · Aug 2, 2021

Keywords

ClinConnect Summary

This clinical trial is looking at the long-term outcomes for patients who have been treated for malignant tumors, which are cancerous growths, at the Fudan University Shanghai Cancer Center. The study aims to gather real-world data on how well patients do after receiving various anti-cancer treatments such as surgery, radiation therapy, and chemotherapy. By analyzing information from their cancer registry, researchers hope to better understand survival rates and factors that influence recovery over time.

To participate in this study, individuals must have completed treatment for a malignant tumor while hospitalized at the center. Unfortunately, those who did not receive treatment during their hospital stay or who have non-cancerous tumors are not eligible. If you join the study, you can expect to contribute to important research that may help improve care for future cancer patients. Additionally, the trial is currently seeking participants of all ages and genders, emphasizing that every patient's experience matters in understanding long-term survivorship.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • All patients who completed tumor treatment (including surgery, radiotherapy, chemotherapy, immunotherapy, etc.) due to malignant tumors based on preoperative or intraoperative evaluation in Fudan University Shanghai Cancer Center during the study period.
• Exclusion Criteria:
• • Patients who have not been treated during hospitalization;
• • Patients with non-malignant tumors.